PF-06840003 10 mg | 99.89%
TargetMol

PF-06840003 (EOS200271) is a specific and oral active IDO-1 inhibitor.
More Information Supplier PagePF-06840003 (EOS200271) is a specific and oral active IDO-1 inhibitor.
More Information Supplier PagePF-06840003 (EOS200271) is a specific and oral active IDO-1 inhibitor.
More Information Supplier PagePF-06840003 (EOS200271) is a specific and oral active IDO-1 inhibitor.
More Information Supplier PageAZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor used for asthma research.
More Information Supplier PageCIL56 is a small molecule that induces cellular ferroptosis through the production of iron-dependent reactive oxygen species (ROS). It also induces accumulation of long-chain saturated, monounsaturated, and polyunsaturated fatty acids in HT-1080 cells in vitro.HT-1080 cells lacking acetyl-CoA carboxylase 1 (ACC1), the rate-limiting enzyme in fatty acid synthesis, exhibit 5-fold resistance to CIL56 treatment, indicating […]
More Information Supplier PageTinoridine (Y-3642) is a non-steroidal anti-inflammatory drug. Tinoridine (5-100 μM), produced a concentration-dependent inhibition on the simultaneous increases in lipid peroxide formation and renin release induced by 50 μM ascorbic acid in the renin granule fraction. On the other hand, indomethacin, hydrocortisone, and prednisolone, which had no ability to inhibit the lipid peroxidation in the […]
More Information Supplier PageTinoridine (Y-3642) is a non-steroidal anti-inflammatory drug. Tinoridine (5-100 μM), produced a concentration-dependent inhibition on the simultaneous increases in lipid peroxide formation and renin release induced by 50 μM ascorbic acid in the renin granule fraction. On the other hand, indomethacin, hydrocortisone, and prednisolone, which had no ability to inhibit the lipid peroxidation in the […]
More Information Supplier Page